Christopher DelOrefice - 20 Nov 2025 Form 4 Insider Report for RESMED INC (RMD)

Reporting relationship: Director
Issuer ticker: RMD
Reported as of: 20 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Nov 2025, 09:49:11 UTC
Prior SEC filing: 02 Sep 2025
Next SEC filing: 01 Dec 2025
Source filing: View source filing
Reporting owner signature: Christpher DelOrefice, Director

Filing notes and source

Key filing fact

Christopher DelOrefice filed Form 4 for RESMED INC (RMD) on 24 Nov 2025.

Key facts

This page summarizes Christopher DelOrefice's Form 4 filing for RESMED INC (RMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Nov 2025, 09:49.

Change

Previous filing in this sequence was filed on 02 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001881430 Primary reporting owner

DelOrefice Christopher

Relationship: Director
Address: 9001 SPECTRUM CENTER BLVD, SAN DIEGO
Signature: Christpher DelOrefice, Director
Signature date: 21 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMD transaction

ResMed Common Stock

Award

Transaction value: $0
Shares: +1,073
Change %: +79%
Price: $0.000000
Shares after: 2,423
Date: 20 Nov 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date.